1 | D (migalastat) | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
2 | D Mannose | 1件: Mannose Mannose | - | - | - | 1件: 13 13 |
3 | D-a-tocopheryl PEG 1000 succinate | - | - | - | - | 1件: 299 299 |
4 | D-aspartate | - | - | - | - | 1件: 13 13 |
5 | D-BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 3件: 10 10, 13, 20 |
6 | D-BIOTINA | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 1件: 13 13 |
7 | D-CURA | - | - | - | - | 1件: 96 96 |
8 | D-Cure | - | - | - | - | 1件: 228 228 |
9 | D-Galactose | 1件: Galactose Galactose | 1件: D04291
D04291
| - | - | 1件: 222 222 |
10 | D-glucitol | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 2件: 28 28, 299 |
11 | D-glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 28 28 |
12 | D-glucitol, 1-deoxy-1-(methylamino)-,2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate (1:1) | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 28 28 |
13 | D-glucose | 2件: D-glucose D-glucose, Dextrose, unspecified form | 1件: D00009
D00009
| - | - | 3件: 49 49, 86, 88 |
14 | D-IVA | - | - | - | - | 1件: 299 299 |
15 | D-methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 84 84 |
16 | D-penicillamine | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
17 | D-penicillamine 150mg | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
18 | D-penicillamine 250 mg | 1件: Penicillamine Penicillamine | 1件: D00496
D00496
| - | - | 1件: 171 171 |
19 | D-Proline | 2件: D-Proline D-Proline, Proline | 1件: D00035
D00035
| - | - | 1件: 97 97 |
20 | D-Serine | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
21 | D-serine (~2g/day) | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
22 | D-SORBITOL | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 1件: 10 10 |
23 | D.3.2 Product code where applicable13: | - | - | - | - | 1件: 193 193 |
24 | D.3.6.2 - dose massima specificare: giornaliera | - | - | - | - | 1件: 86 86 |
25 | D.3.6.2.1 - valore: 45 / 0.45 mg/ml | - | - | - | - | 1件: 97 97 |
26 | D.3.6.2.1 - valore: 5 o 10 mg/kg | - | - | - | - | 1件: 97 97 |
27 | D2E7 | - | - | - | - | 1件: 46 46 |
28 | D569 Tab. | - | - | - | - | 1件: 46 46 |
29 | D6-25-hydroxyvitamin D3 | 1件: Calcifediol Calcifediol | 1件: D00122
D00122
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 299 299 |
30 | D9421-C | - | - | - | - | 1件: 96 96 |
31 | D9421-C capsule 3 mg | - | - | - | - | 1件: 96 96 |
32 | D9421-C, 15mg | - | - | - | - | 1件: 96 96 |
33 | D9421-C, 9mg | - | - | - | - | 1件: 96 96 |
34 | DA-9701 | - | - | - | - | 1件: 6 6 |
35 | DA-9805 45mg | - | - | - | - | 1件: 6 6 |
36 | DA-9805 90mg | - | - | - | - | 1件: 6 6 |
37 | DAAOI-P | - | - | - | - | 1件: 6 6 |
38 | Dabigatran | 1件: Dabigatran Dabigatran | 1件: D09707
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 4件: 51 51, 85, 91, 124 |
39 | Dabigatran etexilate | 2件: Dabigatran Dabigatran, Dabigatran etexilate | 2件: D07144
D07144
,
D09707
| 1件: F2 F2 💬 | 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | 1件: 51 51 |
40 | Dabrafenib | 1件: Dabrafenib Dabrafenib | 1件: D10064
D10064
| 1件: BRAF BRAF 💬 | 44件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Bladder cancer, Breast cancer, Chemical carcinogenesis - reactive oxygen species, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Regulation of actin cytoskeleton, Renal cell carcinoma, Serotonergic synapse, Thyroid cancer, Vascular smooth muscle contraction, cAMP signaling pathway, mTOR signaling pathway 💬 | 1件: 34 34 |
41 | Dabu ying pills | - | - | - | - | 1件: 76 76 |
42 | DAC | - | - | - | - | 1件: 13 13 |
43 | DAC HYP | - | - | - | - | 1件: 13 13 |
44 | DAC-HYP | - | - | - | - | 1件: 13 13 |
45 | Dacepton 5 mg/ml | - | - | - | - | 1件: 6 6 |
46 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | 1件: 6 6 |
47 | DACLIZUMAB | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 8件: 13 13, 56, 60, 65, 97, 107, 283, 284 |
48 | Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
49 | Daclizumab High Yield Process | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
50 | DACLIZUMAB HYP | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
51 | Daclizumab HYP (DAC HYP | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
52 | Daclizumab HYP (DAC HYP) | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
53 | Daclizumab wih Greek suffix | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
54 | Daclizumab with Greek suufix | 1件: Daclizumab Daclizumab | 1件: D03639
D03639
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 13 13 |
55 | DACORTIN | - | - | - | - | 1件: 97 97 |
56 | Dacortin ® | - | - | - | - | 1件: 46 46 |
57 | Dacortín 2,5mg | - | - | - | - | 1件: 222 222 |
58 | Dacortín 30mg | - | - | - | - | 1件: 222 222 |
59 | Dacortín 5mg | - | - | - | - | 1件: 222 222 |
60 | Daily hGH | - | - | - | - | 1件: 78 78 |
61 | Daily ingestion of Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 |
62 | Daily rhGH | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
63 | Daily supplementation | - | - | - | - | 1件: 46 46 |
64 | Dalacin C | - | - | - | - | 1件: 46 46 |
65 | Dalacin C phosphate | 2件: Clindamycin Clindamycin, Phosphate ion | 4件: D00277
D00277
,
D01073
,
D01990
,
D02132
| - | - | 1件: 46 46 |
66 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 4 4, 13 |
67 | Dalfampridine ER | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
68 | Dalfampridine-ER 10mg | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
69 | Dalfampridine-ER 5mg | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
70 | Dalteparin | 1件: Dalteparin Dalteparin | - | - | - | 1件: 222 222 |
71 | Danazol | 1件: Danazol Danazol | 1件: D00289
D00289
| 3件: AR AR, ESR1, PGR 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 60 60, 63, 64, 65, 285 |
72 | DAND (14-Deoxyandrographolide) | - | - | - | - | 1件: 97 97 |
73 | DANICOPAN | 1件: Danicopan Danicopan | 1件: D11641
D11641
| 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 |
74 | Danicopan (ALXN2040) | 1件: Danicopan Danicopan | 1件: D11641
D11641
| 1件: CFD CFD 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 62 62 |
75 | Dantrolene | 1件: Dantrolene Dantrolene | 2件: D02274
D02274
,
D02347
| - | - | 2件: 13 13, 233 |
76 | Dantrolene sodium | 1件: Dantrolene Dantrolene | 2件: D02274
D02274
,
D02347
| - | - | 1件: 233 233 |
77 | Danzhu Fuyuan Granule | - | - | - | - | 1件: 222 222 |
78 | Dapagliflozin | 1件: Dapagliflozin Dapagliflozin | 1件: D08897
D08897
| 1件: SLC5A2 SLC5A2 💬 | - | 2件: 49 49, 222 |
79 | DAPIROLIZUMAB PEGOL | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 2件: 13 13, 49 |
80 | Dapirolizumab pegol (DZP) | 1件: Dapirolizumab pegol Dapirolizumab pegol | - | - | - | 1件: 49 49 |
81 | Dapsone | 1件: Dapsone Dapsone | 1件: D00592
D00592
| - | - | 5件: 35 35, 42, 60, 84, 162 |
82 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 2件: 2 2, 4 |
83 | Daratumumab | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 5件: 16 16, 28, 49, 63, 222 |
84 | Daratumumab and pomalidomide | 2件: Daratumumab Daratumumab, Pomalidomide | 2件: D08976
D08976
,
D10777
| 3件: CD38 CD38, IL6, TNF 💬 | 86件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Nicotinate and nicotinamide metabolism, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Pancreatic secretion, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salivary secretion, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 |
85 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) | 2件: Daratumumab Daratumumab, Hyaluronidase (human recombinant) | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 |
86 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 28 28 |
87 | Daratumumab Injection | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 16 16, 49 |
88 | Darifenacin | 1件: Darifenacin Darifenacin | 2件: D01699
D01699
,
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
89 | Darifenacin (BAY79-4998) | 1件: Darifenacin Darifenacin | 2件: D01699
D01699
,
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 13 13 |
90 | Dark chocolate (85% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
91 | Darunavir | 1件: Darunavir Darunavir | 1件: D03656
D03656
| - | - | 1件: 2 2 |
92 | DARVADSTROCEL | 1件: Darvadstrocel Darvadstrocel | 1件: D11397
D11397
| - | - | 1件: 96 96 |
93 | Darvocet | - | - | - | - | 1件: 70 70 |
94 | Darzalex | 1件: Daratumumab Daratumumab | 1件: D10777
D10777
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 2件: 28 28, 49 |
95 | DAS-001 | - | - | - | - | 1件: 11 11 |
96 | Dasatinib | 1件: Dasatinib Dasatinib | 2件: D03658
D03658
,
D06414
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 51 51, 85 |
97 | Dasatinib + Quercetin | 2件: Dasatinib Dasatinib, Quercetin | 2件: D03658
D03658
,
D06414
| 8件: ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 | 77件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 1件: 85 85 |
98 | Data collection | - | - | - | - | 1件: 65 65 |
99 | Data report | - | - | - | - | 1件: 162 162 |
100 | DaTSCAN | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 4件: 2 2, 5, 6, 17 |
101 | DaTSCAN 74 MBq/ml solution for injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
102 | DATscan and SPECT imaging | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
103 | DaTSCAN™ | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
104 | DaTSCAN™ Ioflupane (123I) Injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 3件: 5 5, 6, 17 |
105 | Daunorubicin | 1件: Daunorubicin Daunorubicin | 2件: D01264
D01264
,
D07776
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 65 65 |
106 | Davunetide | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
107 | Davunetide (AL-108, NAP) | 1件: Davunetide Davunetide | 1件: D09401
D09401
| - | - | 3件: 5 5, 7, 127 |
108 | DAZARLEX | - | - | - | - | 1件: 28 28 |
109 | DB adalimumab 40 mg eow | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
110 | DB adalimumab 40 mg ew | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
111 | DB289 | - | - | - | - | 1件: 65 65 |
112 | DC-TAB | - | - | - | - | 1件: 13 13 |
113 | DC158AM | - | - | - | - | 1件: 6 6 |
114 | DCB | - | - | - | - | 1件: 40 40 |
115 | DCCR | - | - | - | - | 1件: 193 193 |
116 | DCI | - | - | - | - | 2件: 6 6, 299 |
117 | DCI 1020 | - | - | - | - | 1件: 299 299 |
118 | DCR-1171X | - | - | - | - | 1件: 234 234 |
119 | DCR-L1360 | - | - | - | - | 1件: 234 234 |
120 | DCR-PH1 | - | - | - | - | 1件: 234 234 |
121 | DCR-PHXC | - | - | - | - | 1件: 234 234 |
122 | DCS | - | - | - | - | 1件: 6 6 |
123 | DDAND (14-deoxy-11,12-didehydroandrographolide) | - | - | - | - | 1件: 97 97 |
124 | DDAVP | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 75 75, 288 |
125 | DDAVP (Desmopressin) | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 288 288 |
126 | DDS | - | - | - | - | 1件: 90 90 |
127 | De-activated smart device | - | - | - | - | 1件: 299 299 |
128 | Deanol | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
129 | Deanol pyroglutamate | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
130 | Deaxamethasone | - | - | - | - | 1件: 28 28 |
131 | DEBRUMYL | - | - | - | - | 1件: 6 6 |
132 | Decadron | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
133 | Decadron Phosphate, Injectable | 1件: Phosphate ion Phosphate ion | - | - | - | 1件: 70 70 |
134 | Decitabine | 1件: Decitabine Decitabine | 1件: D03665
D03665
| 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬 | 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer 💬 | 2件: 60 60, 63 |
135 | Decolonization | - | - | - | - | 1件: 299 299 |
136 | Decortin | - | - | - | - | 2件: 46 46, 113 |
137 | DECORTIN (PREDNISONA) 5 MG COMPRIMIDOS | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
138 | Decortin 20 mg | - | - | - | - | 1件: 96 96 |
139 | Decortin 5 mg | - | - | - | - | 1件: 96 96 |
140 | Decortin 5mg tablets | - | - | - | - | 1件: 46 46 |
141 | Decortin H | - | - | - | - | 3件: 66 66, 97, 145 |
142 | Decortin H 1 mg | - | - | - | - | 1件: 97 97 |
143 | Decortin H 10mg | - | - | - | - | 1件: 97 97 |
144 | Decortin H 20mg | - | - | - | - | 1件: 97 97 |
145 | Decortin H 50 mg | - | - | - | - | 1件: 97 97 |
146 | Decortin H 5mg | - | - | - | - | 1件: 97 97 |
147 | Decortin® | - | - | - | - | 1件: 46 46 |
148 | Decrease Tocilizumab, Abatacept | 2件: Abatacept Abatacept, Tocilizumab | 2件: D02596
D02596
,
D03203
| 3件: CD80 CD80, CD86, IL6R 💬 | 24件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
149 | Dectancyl | - | - | - | - | 1件: 81 81 |
150 | Deep Brain Stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
151 | Defanyl 50 and 100 mg | - | - | - | - | 1件: 46 46 |
152 | Deferasirox | 1件: Deferasirox Deferasirox | 1件: D03669
D03669
| - | - | 3件: 254 254, 284, 286 |
153 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
154 | Deferiprone (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
155 | Deferiprone 20mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
156 | Deferiprone 30mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
157 | Deferiprone 600 mg delayed release tablet | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
158 | Deferiprone 80 mg/mL oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
159 | Deferiprone 80 mg/mL oral solution (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
160 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 2 2, 6 |
161 | Deferiprone oral solution | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
162 | Deferiprone treated | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
163 | Deferitazole | 1件: Deferitazole Deferitazole | 1件: D10388
D10388
| - | - | 1件: 284 284 |
164 | Deferoxamine | 1件: Deferoxamine Deferoxamine | 2件: D01186
D01186
,
D03670
| - | - | 2件: 284 284, 286 |
165 | DEFEROXAMINE MESILATE | 1件: Deferoxamine Deferoxamine | 2件: D01186
D01186
,
D03670
| - | - | 1件: 286 286 |
166 | DEFLAN*10CPR 6MG | - | - | - | - | 1件: 113 113 |
167 | Deflazacort | 1件: Deflazacort Deflazacort | 1件: D03671
D03671
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 30 30, 113 |
168 | Deflazacort 6 mg Tablets | 1件: Deflazacort Deflazacort | 1件: D03671
D03671
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 |
169 | Dehydrated Alcohol (Absolute Alcohol) BP for Injection | 1件: Ethanol Ethanol | 4件: D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | 1件: 279 279 |
170 | Dehydrated human amnion/chorion membrane | - | - | - | - | 1件: 269 269 |
171 | Dehydroepiandrosterone | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 5件: 49 49, 53, 83, 96, 113 |
172 | Dehydroepiandrosterone (DHEA) | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 49 49 |
173 | Dehydroepiandrosterone 100 and 400 mg | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 113 113 |
174 | Dehydroepiandrosterone [DHEA] | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 96 96 |
175 | Dekavil | - | - | - | - | 2件: 46 46, 97 |
176 | Dekristol | - | - | - | - | 2件: 13 13, 97 |
177 | Dekristol 20.000 ie | - | - | - | - | 1件: 96 96 |
178 | Dekristol 20000 IE | - | - | - | - | 1件: 13 13 |
179 | Dekristol® 400-Tabletten | - | - | - | - | 1件: 13 13 |
180 | Dekristol®-Tablette 1 (400 IE) | - | - | - | - | 1件: 13 13 |
181 | Deksmedetomidiini | - | - | - | - | 1件: 70 70 |
182 | Delayed and extended release mesalazine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
183 | Delayed Release 6 mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 96 96 |
184 | Delayed Release 6MP or Calcitriol vs. Purinethol | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 |
185 | Deligoparin | - | - | - | - | 1件: 97 97 |
186 | Delix | - | - | - | - | 1件: 218 218 |
187 | Delmitide acetate | 1件: Acetate Acetate | - | - | - | 1件: 97 97 |
188 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 36 |
189 | Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: D00306
D00306
,
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 8 8 |
190 | DELTACORTENE | - | - | - | - | 2件: 43 43, 97 |
191 | Deltacortene 10 cpr 25mg | - | - | - | - | 1件: 97 97 |
192 | Deltacortene 20 cpr 5mg | - | - | - | - | 1件: 97 97 |
193 | DELTACORTENE FORTE*10CPR 25MG | - | - | - | - | 2件: 46 46, 97 |
194 | DELTACORTENE*10CPR 25MG | - | - | - | - | 1件: 84 84 |
195 | DELTACORTENE*20CPR 5MG | - | - | - | - | 3件: 49 49, 97, 113 |
196 | Deltacortril | - | - | - | - | 1件: 46 46 |
197 | Deltacortril Enteric | - | - | - | - | 1件: 46 46 |
198 | DEMESTRIL SEPTEM | - | - | - | - | 1件: 13 13 |
199 | Demineralized Bone Matrix | - | - | - | - | 1件: 70 70 |
200 | Denosumab | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 7件: 46 46, 50, 93, 95, 96, 274, 299 |
201 | Denosumab - - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 |
202 | Denosumab - Immunoglobulin G2 Human Monoclonal Antibody to RANK Ligand | 1件: Denosumab Denosumab | 1件: D03684
D03684
| 1件: TNFSF11 TNFSF11 💬 | 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 1件: 274 274 |
203 | Dental evaluation | - | - | - | - | 1件: 78 78 |
204 | Denufosol | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
205 | Denufosol tetrasodium (INS37217) | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
206 | Denufosol Tetrasodium (INS37217) Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
207 | Denufosol tetrasodium Inhalation Solution | 1件: Denufosol Denufosol | - | - | - | 1件: 299 299 |
208 | Denusomab | - | - | - | - | 1件: 274 274 |
209 | Deoxynojirimycin | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
210 | Depakine | - | - | - | - | 2件: 102 102, 233 |
211 | DEPAKINE CHRONO 500 mg | - | - | - | - | 1件: 233 233 |
212 | DEPAKINE CHRONO® 500 mg | - | - | - | - | 1件: 233 233 |
213 | DEPALGOS*20+325MG 28CPR RP | - | - | - | - | 1件: 46 46 |
214 | DEPELESTAT | - | - | - | - | 1件: 299 299 |
215 | Depemedrone | - | - | - | - | 1件: 46 46 |
216 | Depemokimab | - | - | - | - | 1件: 44 44 |
217 | Depleted Stem Cell Transplant | - | - | - | - | 1件: 285 285 |
218 | Depletion in CD45RA graft donor | - | - | - | - | 1件: 65 65 |
219 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | 2件: 49 49, 51 |
220 | Depo Medrol | - | - | - | - | 1件: 46 46 |
221 | Depo-Medrone | - | - | - | - | 1件: 46 46 |
222 | DepoMedrol | - | - | - | - | 1件: 70 70 |
223 | Depot leuprolide acetate 3.75 mg | 2件: Acetate Acetate, Leuprolide | 1件: D00989
D00989
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
224 | Depot tetracosactide | 1件: Tetracosactide Tetracosactide | 1件: D00284
D00284
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 |
225 | Deprakine | - | - | - | - | 1件: 256 256 |
226 | Dermoval | - | - | - | - | 2件: 35 35, 162 |
227 | Dersalazina sodica | - | - | - | - | 1件: 97 97 |
228 | Dersalazine | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 |
229 | Dersalazine sodium | 1件: Dersalazine Dersalazine | - | - | - | 1件: 97 97 |
230 | Dersimelagon | - | - | - | - | 2件: 51 51, 254 |
231 | DESAMETASONE | - | - | - | - | 1件: 28 28 |
232 | Descartes-08 | - | - | - | - | 1件: 11 11 |
233 | Desert Harvest Aloe Vera Capsules | 1件: Aloe vera leaf Aloe vera leaf | - | - | - | 1件: 226 226 |
234 | Desferal | 1件: Deferoxamine Deferoxamine | 2件: D01186
D01186
,
D03670
| - | - | 2件: 284 284, 286 |
235 | Desferasirox | - | - | - | - | 1件: 60 60 |
236 | Desflurane | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 2件: 22 22, 296 |
237 | Desflurane anesthetics | 1件: Desflurane Desflurane | 1件: D00546
D00546
| - | - | 1件: 296 296 |
238 | Desipramine | 1件: Desipramine Desipramine | 2件: D00812
D00812
,
D07791
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 120 120, 156 |
239 | Desloratadine | 1件: Desloratadine Desloratadine | 1件: D03693
D03693
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
240 | Desloratadine given orally | 1件: Desloratadine Desloratadine | 1件: D03693
D03693
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
241 | Desmopressin | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 5件: 6 6, 64, 72, 225, 288 |
242 | Desmopressin Acetat | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 6 6 |
243 | Desmopressin acetate | 2件: Acetate Acetate, Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 |
244 | DESMOPRESSIN ACETATE TRIHYDRATE | 2件: Acetate Acetate, Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 |
245 | Desmopressin intranasal | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
246 | Desmopressin Oral Melt | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 72 72 |
247 | Desmopressine | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 225 225, 288 |
248 | Desmopressine nasal spray 10 mg/ml, flacon 60 doses | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 225 225 |
249 | Desmotabs | - | - | - | - | 1件: 6 6 |
250 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | 1件: 6 6 |
251 | Desmotabs® 0,2mg Tabletten | - | - | - | - | 1件: 6 6 |
252 | Desogestrel | 1件: Desogestrel Desogestrel | 1件: D02367
D02367
| 2件: ESR1 ESR1, PGR 💬 | 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 |
253 | Desoxyribonuclease | 1件: Desoxyribonuclease Desoxyribonuclease | - | - | - | 1件: 299 299 |
254 | Detemir | 1件: Insulin detemir Insulin detemir | 1件: D04539
D04539
| 1件: INSR INSR 💬 | 22件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 299 299 |
255 | Determination of drug effects through amantadine cessation | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
256 | Determination of growth hormone status | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 78 78 |
257 | Determination of objective and subjective pain threshold | - | - | - | - | 1件: 17 17 |
258 | Detoxifying agents for antineoplastic treatment | - | - | - | - | 2件: 299 299, 337 |
259 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: D11817
D11817
| 1件: TYK2 TYK2 💬 | 16件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis 💬 | 2件: 96 96, 97 |
260 | Deuterated Ivacaftor | 1件: Ivacaftor Ivacaftor | 1件: D09916
D09916
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
261 | Deutetrabenazine | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
262 | Deutetrabenazine Oral Tablet [Austedo] | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
263 | DEUTIVACAFTOR | 1件: Deutivacaftor Deutivacaftor | 1件: D11423
D11423
| 1件: CFTR CFTR 💬 | 8件: ABC transporters ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬 | 1件: 299 299 |
264 | DEX284 | - | - | - | - | 1件: 85 85 |
265 | DEXA scan | - | - | - | - | 3件: 19 19, 46, 96 |
266 | DEXA, blood tests, H.G.P.O, osseous age. | - | - | - | - | 2件: 78 78, 193 |
267 | Dexametasona | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
268 | Dexametasone | - | - | - | - | 1件: 28 28 |
269 | Dexametasone Fosfato Sodico | - | - | - | - | 1件: 65 65 |
270 | Dexamethason | - | - | - | - | 4件: 13 13, 28, 46, 331 |
271 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 25件: 13 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 |
272 | Dexamethasone (1 cycle) | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
273 | Dexamethasone (4 cycles) | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
274 | Dexamethasone (50mg 1dd6, 3 consecutive days/month) | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 35 35 |
275 | Dexamethasone (or equivalent) | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 257 257 |
276 | Dexamethasone 0,1 mg Tablets | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
277 | Dexamethasone 0,5mg | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
278 | Dexamethasone 0.5mg Tablet | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
279 | Dexamethasone 0.5mg/5ml solution | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 |
280 | Dexamethasone 0.5mg/5ml solution in Mucolox™ | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 35 35, 162 |
281 | Dexamethasone 1,5 mg Tablets | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
282 | Dexamethasone 21-dihydrogen phosphate | 3件: Dexamethasone Dexamethasone, Hydrogen, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
283 | Dexamethasone 21-phosphate | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
284 | Dexamethasone 2mg Tablets | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
285 | Dexamethasone 4 mg JENAPHARM | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
286 | Dexamethasone Abcur | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
287 | Dexamethasone and Rituximab | 2件: Dexamethasone Dexamethasone, Rituximab | 10件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D02994
| 2件: MS4A1 MS4A1, NR3C1 💬 | 2件: Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | 1件: 63 63 |
288 | Dexamethasone given orally | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
289 | Dexamethasone injection | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
290 | Dexamethasone oral tablet 8mg (Dexamethasone Krka tablets(8mg), Warsaw, Poland). | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 235 235 |
291 | Dexamethasone Parotid Irrigation | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 53 53 |
292 | DEXAMETHASONE SODIUM PHOSPHATE | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 65 65, 70, 96 |
293 | Dexamethasone sodium phosphate (soluzione 25mg/ml) | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
294 | Dexamethasone sodium phosphate 250 mg/ 10 ml | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
295 | Dexamethasone sodium phosphate 250 mg/10 ml solution | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 299 299 |
296 | DEXAMETHASONE SODIUM PHOSPHATE PH. EUR. | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
297 | DEXAMETHASONE SODIUM SULFATE | 3件: Dexamethasone Dexamethasone, Sodium sulfate, Sulfate ion | 10件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D05877
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
298 | Dexamethasone soduim phosphate | 2件: Dexamethasone Dexamethasone, Phosphate ion | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
299 | Dexamethasone, 40 mg | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 28 28 |
300 | Dexamethasone, procarbazine | 2件: Dexamethasone Dexamethasone, Procarbazine | 11件: D00292
D00292
,
D00478
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
,
D08423
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
301 | Dexaton | - | - | - | - | 1件: 28 28 |
302 | Dexchlorpheniramine | 1件: Dexchlorpheniramine Dexchlorpheniramine | 1件: D07803
D07803
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 49 |
303 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 |
304 | Dexlansoprazole | 1件: Dexlansoprazole Dexlansoprazole | 1件: D08903
D08903
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 98 98 |
305 | DEXMEDETOMIDINA | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
306 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
307 | Dexmedetomidine 1 | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
308 | Dexmedetomidine 2 | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
309 | Dexmedetomidine 3 | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 280 280 |
310 | Dexmedetomidine group | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
311 | DEXMEDETOMIDINE HYDROCHLORIDE | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
312 | Dexmedetomidine Hydrochloride Infusion | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
313 | Dexmedetomidine with ropivacaine | 2件: Dexmedetomidine Dexmedetomidine, Ropivacaine | 4件: D00514
D00514
,
D01205
,
D04048
,
D08490
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 5件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 70 70 |
314 | Dexpramipexole | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
315 | Dexpramipexole (dose 1) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
316 | Dexpramipexole (dose 2) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
317 | Dexpramipexole Dichydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
318 | Dexpramipexole Dihydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
319 | Dexrazoxane | 1件: Dexrazoxane Dexrazoxane | 1件: D03730
D03730
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
320 | Dexrazoxane (DRZ) plus Mitoxantrone (MX) | 2件: Dexrazoxane Dexrazoxane, Mitoxantrone | 3件: D02166
D02166
,
D03730
,
D08224
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
321 | Dextran | 1件: Dextran Dextran | 1件: D00060
D00060
| - | - | 5件: 2 2, 62, 79, 96, 97 |
322 | DEXTRAN 1 FOR INJECTION | 1件: Dextran Dextran | 1件: D00060
D00060
| - | - | 1件: 97 97 |
323 | Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS) | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
324 | Dextran sulfate adsorption | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 79 79 |
325 | DEXTRAN SULFATE SODIUM | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
326 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
327 | Dextromethorphan 30 mg | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 |
328 | Dextromethorphan and Caffeine | 2件: Caffeine Caffeine, Dextromethorphan | 5件: D00528
D00528
,
D00848
,
D01453
,
D03742
,
D03744
| 17件: ADORA1 ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 | 37件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 78 78 |
329 | Dextromethorphan HBr and quinidine sulfate | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
330 | DEXTROMETHORPHAN HYDROBROMIDE | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 13 13, 46 |
331 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
332 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
333 | Dextromethorphan/Quinidine | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
334 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 8 8 |
335 | Dextrometorfano | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 |
336 | DEXTROMETORFANO HIDROBROMURO | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 |
337 | Dextrometorfano/Quinidina | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
338 | Dextrose | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 5件: 56 56, 60, 65, 70, 226 |
339 | Dextrose, 5% in Water | 2件: Dextrose, unspecified form Dextrose, unspecified form, Water | 1件: D00001
D00001
| - | - | 1件: 65 65 |
340 | Dezamizumab | 1件: Dezamizumab Dezamizumab | 1件: D11471
D11471
| 1件: APCS APCS 💬 | - | 1件: 28 28 |
341 | DF2156A | - | - | - | - | 1件: 162 162 |
342 | DFO | - | - | - | - | 3件: 46 46, 284, 286 |
343 | DFV890 | - | - | - | - | 1件: 106 106 |
344 | DGH | - | - | - | - | 1件: 78 78 |
345 | DHA | - | - | - | - | 8件: 6 6, 46, 48, 49, 94, 113, 299, 301 |
346 | DHC | - | - | - | - | 1件: 310 310 |
347 | DHEA | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 3件: 49 49, 86, 96 |
348 | DHEA tablet | 1件: Prasterone Prasterone | 1件: D08409
D08409
| 3件: AR AR, ESR1, ESR2 💬 | 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 86 86 |
349 | DI-17E6 | - | - | - | - | 1件: 51 51 |
350 | DIACEREIN | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 3件: 36 36, 46, 63 |
351 | Diacerein 1% Ointment | 1件: Diacerein Diacerein | 1件: D07270
D07270
| - | - | 1件: 36 36 |
352 | Diacerin cream | - | - | - | - | 1件: 36 36 |
353 | DIACOMIT | 1件: Stiripentol Stiripentol | 1件: D05928
D05928
| - | - | 1件: 140 140 |
354 | DIACOMIT (Stiripentol) | 1件: Stiripentol Stiripentol | 1件: D05928
D05928
| - | - | 1件: 140 140 |
355 | Diagnostic Test: 11C-ER176 | - | - | - | - | 1件: 46 46 |
356 | Diagnostic Test: 11C-MC1 | - | - | - | - | 1件: 46 46 |
357 | Diagnostic Test: 11C-UCB-J PET-CT | - | - | - | - | 1件: 8 8 |
358 | Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 96 96 |
359 | Diagnostic Test: 18F-FDG PET-MR | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 8 8 |
360 | Diagnostic Test: 18F-FDG-PET/MRI | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 84 84 |
361 | Diagnostic Test: 18F-GE180-PET/MRI | - | - | - | - | 1件: 84 84 |
362 | Diagnostic Test: 24-hour Urine test | - | - | - | - | 1件: 75 75 |
363 | Diagnostic Test: 30 seconds sit to stand test | - | - | - | - | 1件: 113 113 |
364 | Diagnostic Test: 68-Ga HA-DOTATATE PET/CT | 1件: Dotatate Dotatate | - | - | - | 1件: 41 41 |
365 | Diagnostic Test: 68Ga-DOTA-TOC PET/CT | - | - | - | - | 1件: 84 84 |
366 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
367 | Diagnostic Test: Abdominal and liver ultrasound. | - | - | - | - | 1件: 229 229 |
368 | Diagnostic Test: Adalimumab serum trough concentration | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
369 | Diagnostic Test: Adalimumab trough concentration | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
370 | Diagnostic Test: Air venous plethysmography | - | - | - | - | 1件: 58 58 |
371 | Diagnostic Test: Antibodies to golimumab | 1件: Golimumab Golimumab | 1件: D04358
D04358
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
372 | Diagnostic Test: Arginine | 1件: Arginine Arginine | 1件: D02982
D02982
| - | - | 1件: 78 78 |
373 | Diagnostic Test: Audiology assessmentwith ABR | - | - | - | - | 1件: 19 19 |
374 | Diagnostic Test: Auto-Assessment Manikins (SAM) | - | - | - | - | 1件: 6 6 |
375 | Diagnostic Test: Barcelona test (BT) | - | - | - | - | 1件: 6 6 |
376 | Diagnostic Test: Barium Esophagram | 1件: Barium Barium | - | - | - | 1件: 98 98 |
377 | Diagnostic Test: Baseline blood tests | - | - | - | - | 1件: 83 83 |
378 | Diagnostic Test: Beam test to predict falls | 1件: Tricyclazole Tricyclazole | - | - | - | 1件: 6 6 |
379 | Diagnostic Test: Beck depression inventory | - | - | - | - | 1件: 113 113 |
380 | Diagnostic Test: Beck depression inventory fast screen (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
381 | Diagnostic Test: Beck Depression Inventory-II (BDI-II) | - | - | - | - | 1件: 6 6 |
382 | Diagnostic Test: Berg balance scale | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 113 113 |
383 | Diagnostic Test: Biotherapy Prescription with SinnoTest® software | - | - | - | - | 1件: 46 46 |
384 | Diagnostic Test: Blood analysis for hypercalcemia's control | - | - | - | - | 1件: 18 18 |
385 | Diagnostic Test: blood drawing in healthy controls | - | - | - | - | 1件: 65 65 |
386 | Diagnostic Test: blood drawing in patients with WAS | - | - | - | - | 1件: 65 65 |
387 | Diagnostic Test: blood sample , doppler of uterine vessel and placenta | - | - | - | - | 1件: 288 288 |
388 | Diagnostic Test: Blood test | - | - | - | - | 1件: 75 75 |
389 | Diagnostic Test: Bone density scan (DEXA | - | - | - | - | 1件: 19 19 |
390 | Diagnostic Test: Bone Mineral Density (DEXA) scan | - | - | - | - | 1件: 98 98 |
391 | Diagnostic Test: Borg Scale | - | - | - | - | 3件: 3 3, 15, 256 |
392 | Diagnostic Test: Brain MRI | - | - | - | - | 2件: 25 25, 229 |
393 | Diagnostic Test: Brief Pain Inventory (BPI) (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
394 | Diagnostic Test: Brief Pain Inventory Short-Form | - | - | - | - | 1件: 113 113 |
395 | Diagnostic Test: Calprotectin | - | - | - | - | 1件: 97 97 |
396 | Diagnostic Test: Candy Glucose Tolerance Test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
397 | Diagnostic Test: Cardiac MRI (Gadolinium enhanced) | 1件: Gadolinium Gadolinium | - | - | - | 1件: 86 86 |
398 | Diagnostic Test: Clonidine | 1件: Clonidine Clonidine | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 78 78 |
399 | Diagnostic Test: CMRI | - | - | - | - | 2件: 51 51, 86 |
400 | Diagnostic Test: colchicine level measurement | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 266 266 |
401 | Diagnostic Test: Colonoscopy | - | - | - | - | 1件: 97 97 |
402 | Diagnostic Test: Continuous glucose monitoring | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
403 | Diagnostic Test: Cortisol level | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
404 | Diagnostic Test: Cosyntropin stimulation test | 1件: Tetracosactide Tetracosactide | 1件: D00284
D00284
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 83 83 |
405 | Diagnostic Test: Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence | 1件: Creatine Creatine | - | - | - | 1件: 21 21 |
406 | Diagnostic Test: CRQ | - | - | - | - | 1件: 46 46 |
407 | Diagnostic Test: Dexa scan | - | - | - | - | 1件: 299 299 |
408 | Diagnostic Test: Dexamethasone test | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 |
409 | Diagnostic Test: Disease activity | - | - | - | - | 1件: 46 46 |
410 | Diagnostic Test: DM1-ActivC | - | - | - | - | 1件: 113 113 |
411 | Diagnostic Test: Echocardiogram | - | - | - | - | 1件: 19 19 |
412 | Diagnostic Test: Echocardiography | - | - | - | - | 1件: 58 58 |
413 | Diagnostic Test: Echocardiography at M24 | - | - | - | - | 1件: 19 19 |
414 | Diagnostic Test: Echocardiography at T0 | - | - | - | - | 1件: 19 19 |
415 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
416 | Diagnostic Test: Electrocardiogram | - | - | - | - | 1件: 58 58 |
417 | Diagnostic Test: Electrocardiogram (EKG) | - | - | - | - | 1件: 19 19 |
418 | Diagnostic Test: Endogenous thrombin potential | 1件: Thrombin Thrombin | 1件: D00090
D00090
| - | - | 2件: 86 86, 88 |
419 | Diagnostic Test: Endoscopy while on study drug | - | - | - | - | 1件: 98 98 |
420 | Diagnostic Test: Entire-body PET-CT scans | - | - | - | - | 1件: 13 13 |
421 | Diagnostic Test: Exercise Stress Transthoracic Echocardiogram | - | - | - | - | 1件: 58 58 |
422 | Diagnostic Test: Exercise test | - | - | - | - | 1件: 19 19 |
423 | Diagnostic Test: Fatigue and Daytime Sleepiness Scale | - | - | - | - | 1件: 113 113 |
424 | Diagnostic Test: Fatigue Severity and Disability Scale (FSS) (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
425 | Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging | - | - | - | - | 1件: 84 84 |
426 | Diagnostic Test: Fecal microbiome probiotic | - | - | - | - | 1件: 294 294 |
427 | Diagnostic Test: fibrinogen plasma concentration, coagulation factor XIII activity | 2件: Factor XIII (human) Factor XIII (human), Fibrinogen human | - | - | - | 1件: 288 288 |
428 | Diagnostic Test: Flutemetamol F18 Injection | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
429 | Diagnostic Test: Frontal assessment battery (FAB) | - | - | - | - | 1件: 6 6 |
430 | Diagnostic Test: functional and antigenic C1 inhibitor | 1件: Human C1-esterase inhibitor Human C1-esterase inhibitor | - | - | - | 1件: 65 65 |
431 | Diagnostic Test: Functional Index-2 | - | - | - | - | 1件: 113 113 |
432 | Diagnostic Test: Functional residual capacity | - | - | - | - | 1件: 294 294 |
433 | Diagnostic Test: gait analysis | - | - | - | - | 1件: 149 149 |
434 | Diagnostic Test: Gastrointestinal Quality of Life index | - | - | - | - | 1件: 98 98 |
435 | Diagnostic Test: Gated MRI scan | - | - | - | - | 1件: 75 75 |
436 | Diagnostic Test: genetic sequencing | - | - | - | - | 1件: 298 298 |
437 | Diagnostic Test: German Pain Inventory (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
438 | Diagnostic Test: Global Deterioration Scale (GDS) | - | - | - | - | 1件: 6 6 |
439 | Diagnostic Test: Golimumab trough levels | 1件: Golimumab Golimumab | 1件: D04358
D04358
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 |
440 | Diagnostic Test: Gonadorelin acetate and Triptorelin acetate | 3件: Acetate Acetate, Gonadorelin, Triptorelin | 5件: D00988
D00988
,
D03267
,
D04361
,
D06247
,
D08027
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
441 | Diagnostic Test: GSGC | - | - | - | - | 1件: 113 113 |
442 | Diagnostic Test: Hand opening time | - | - | - | - | 1件: 113 113 |
443 | Diagnostic Test: Handheld Dynamometry (HHD) | - | - | - | - | 3件: 3 3, 15, 256 |
444 | Diagnostic Test: Hearing assessment | - | - | - | - | 1件: 122 122 |
445 | Diagnostic Test: Height measurement | - | - | - | - | 1件: 98 98 |
446 | Diagnostic Test: Hemoglobin A1c | 1件: Hemoglobin Hemoglobin | - | - | - | 1件: 298 298 |
447 | Diagnostic Test: High-resolution manometry | - | - | - | - | 1件: 98 98 |
448 | Diagnostic Test: Histology | - | - | - | - | 1件: 97 97 |
449 | Diagnostic Test: Holter ECG | - | - | - | - | 1件: 58 58 |
450 | Diagnostic Test: Imaging | - | - | - | - | 1件: 51 51 |
451 | Diagnostic Test: Infant PFT | - | - | - | - | 1件: 299 299 |
452 | Diagnostic Test: initial fecal microbiome | - | - | - | - | 1件: 294 294 |
453 | Diagnostic Test: initial pulmonary microbiome | - | - | - | - | 1件: 294 294 |
454 | Diagnostic Test: initial VOC | - | - | - | - | 1件: 294 294 |
455 | Diagnostic Test: Injected abdominal CT | - | - | - | - | 1件: 299 299 |
456 | Diagnostic Test: Iontophoresis sessions in forearm of subjects with pilocarpine | 1件: Pilocarpine Pilocarpine | 3件: D00525
D00525
,
D02200
,
D05478
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 |
457 | Diagnostic Test: Laboratory assessment: calcium | 1件: Calcium Calcium | - | - | - | 3件: 3 3, 15, 256 |
458 | Diagnostic Test: Laboratory assessment: Creatine kinase | 1件: Creatine Creatine | - | - | - | 3件: 3 3, 15, 256 |
459 | Diagnostic Test: Laboratory assessment: magnesium | 1件: Magnesium Magnesium | - | - | - | 3件: 3 3, 15, 256 |
460 | Diagnostic Test: Laboratory assessment: phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 3件: 3 3, 15, 256 |
461 | Diagnostic Test: Laboratory assessment: Vitamin D Level | 1件: Vitamin D Vitamin D | - | - | - | 3件: 3 3, 15, 256 |
462 | Diagnostic Test: Laboratory testing | - | - | - | - | 2件: 84 84, 271 |
463 | Diagnostic Test: Laboratory tests | - | - | - | - | 1件: 19 19 |
464 | Diagnostic Test: Light transmission aggregometry | - | - | - | - | 2件: 86 86, 88 |
465 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
466 | Diagnostic Test: Lung Clearance Index | - | - | - | - | 1件: 299 299 |
467 | Diagnostic Test: Manual muscle testing | - | - | - | - | 1件: 113 113 |
468 | Diagnostic Test: Maximum oxygen uptake | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 294 294 |
469 | Diagnostic Test: McGill pain questionnaire | - | - | - | - | 1件: 113 113 |
470 | Diagnostic Test: Measurement of serum level of anti-dementia drug | - | - | - | - | 1件: 6 6 |
471 | Diagnostic Test: Measurement of Sweat Chloride and Sweat Bromide | 1件: Chloride ion Chloride ion | - | - | - | 1件: 299 299 |
472 | Diagnostic Test: Memory alteration test (M@T) | - | - | - | - | 1件: 6 6 |
473 | Diagnostic Test: Metabolomics | - | - | - | - | 1件: 85 85 |
474 | Diagnostic Test: Methionine/homocysteine Dosage | 2件: Homocysteine Homocysteine, Methionine | 2件: D00019
D00019
,
D04983
| - | - | 1件: 229 229 |
475 | Diagnostic Test: Mini Cognitive Examination (MCE) | - | - | - | - | 1件: 6 6 |
476 | Diagnostic Test: Mixed Meal Tolerance Test | - | - | - | - | 1件: 298 298 |
477 | Diagnostic Test: Multi-modal photoacoustic/ultrasonic (PA/US) imaging system | - | - | - | - | 1件: 46 46 |
478 | Diagnostic Test: Muscle ultrasound | - | - | - | - | 3件: 3 3, 15, 256 |
479 | Diagnostic Test: Myotonia (from Individualised Neuromuscular Quality of Life Questionnaire) | - | - | - | - | 1件: 113 113 |
480 | Diagnostic Test: Myotonia Behaviour scale | - | - | - | - | 1件: 113 113 |
481 | Diagnostic Test: Nasal brushing | - | - | - | - | 1件: 299 299 |
482 | Diagnostic Test: Neuropsychological assessment | - | - | - | - | 2件: 6 6, 127 |
483 | Diagnostic Test: Nicotine and cotinine serum levels | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 13 13 |
484 | Diagnostic Test: Nociceptor flexor reflex | - | - | - | - | 1件: 149 149 |
485 | Diagnostic Test: Ocular Coherence Tomography-Angiography (OCT-A) | - | - | - | - | 2件: 90 90, 301 |
486 | Diagnostic Test: Olfactory (smell) function testing | - | - | - | - | 1件: 122 122 |
487 | Diagnostic Test: Oral glucose tolerance test | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 3件: 13 13, 65, 299 |
488 | Diagnostic Test: Other exploratory blood biomarkers | - | - | - | - | 1件: 298 298 |
489 | Diagnostic Test: P-MPA concentration | - | - | - | - | 1件: 51 51 |
490 | Diagnostic Test: parasitological diagnostics (coproscopy) | - | - | - | - | 1件: 97 97 |
491 | Diagnostic Test: Passive tidal breathing | - | - | - | - | 1件: 299 299 |
492 | Diagnostic Test: PET Imaging | - | - | - | - | 1件: 85 85 |
493 | Diagnostic Test: PET with [11C]Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 13 13 |
494 | Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab | 1件: Bevacizumab Bevacizumab | 1件: D06409
D06409
| 1件: VEGFA VEGFA 💬 | 24件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 86 86 |
495 | Diagnostic Test: Phosphorous Magnetic Resonance Spectroscopy | 1件: Phosphorus Phosphorus | - | - | - | 1件: 58 58 |
496 | Diagnostic Test: Physical Examination and Questionnaires | - | - | - | - | 1件: 98 98 |
497 | Diagnostic Test: Plasma a-Gal A activity | - | - | - | - | 1件: 19 19 |
498 | Diagnostic Test: Plasmatic 3-O-Methyldopa dosage | 1件: Methyldopa Methyldopa | 2件: D00405
D00405
,
D08205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 323 323 |
499 | Diagnostic Test: Platelet function analyzer-100 | - | - | - | - | 2件: 86 86, 88 |
500 | Diagnostic Test: Positive and Negative Affect Scale (PANAS) | - | - | - | - | 1件: 6 6 |
501 | Diagnostic Test: Postoperative laboratory blood tests at 24 hour | - | - | - | - | 1件: 235 235 |
502 | Diagnostic Test: Postoperative laboratory blood tests at 6 hour | - | - | - | - | 1件: 235 235 |
503 | Diagnostic Test: Postoperative laboratory drainage fluid tests at 24 hour | - | - | - | - | 1件: 235 235 |
504 | Diagnostic Test: Preoparative blood laboratory tests | - | - | - | - | 1件: 235 235 |
505 | Diagnostic Test: Pressure pain threshold | - | - | - | - | 4件: 3 3, 15, 113, 256 |
506 | Diagnostic Test: PTH measurements post-thyroidectomy (at 5 and 60 min post thyroid removal) | - | - | - | - | 1件: 235 235 |
507 | Diagnostic Test: Pulmonary function test | - | - | - | - | 1件: 51 51 |
508 | Diagnostic Test: Pulmonary microbiome probiotic | - | - | - | - | 1件: 294 294 |
509 | Diagnostic Test: Quantitative muscle testing | - | - | - | - | 1件: 113 113 |
510 | Diagnostic Test: Quick Motor Function Test | - | - | - | - | 4件: 3 3, 15, 113, 256 |
511 | Diagnostic Test: R-PAct | - | - | - | - | 1件: 113 113 |
512 | Diagnostic Test: R-PAct (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
513 | Diagnostic Test: Rectosigmoidoscopy | - | - | - | - | 1件: 97 97 |
514 | Diagnostic Test: Respiratory Muscle Strength | - | - | - | - | 1件: 6 6 |
515 | Diagnostic Test: Retrospective evaluation of endoscopy prior to study drug | - | - | - | - | 1件: 98 98 |
516 | Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT) | - | - | - | - | 1件: 6 6 |
517 | Diagnostic Test: RNA and neopterin detection | 1件: Neopterin Neopterin | - | - | - | 1件: 65 65 |
518 | Diagnostic Test: Rotational thromboelastometry | - | - | - | - | 2件: 86 86, 88 |
519 | Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire) | - | - | - | - | 3件: 3 3, 15, 256 |
520 | Diagnostic Test: Routine MRI scan | - | - | - | - | 1件: 75 75 |
521 | Diagnostic Test: Saliva swab | - | - | - | - | 1件: 75 75 |
522 | Diagnostic Test: Scale for Assessment and Rating of Ataxia | - | - | - | - | 1件: 113 113 |
523 | Diagnostic Test: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation | 2件: Acetylcholine Acetylcholine, Neostigmine | 1件: D08261
D08261
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 11 11 |
524 | Diagnostic Test: Serum biomarkers | - | - | - | - | 1件: 98 98 |
525 | Diagnostic Test: serum leucine-rich alpha-2 glycoprotein (LRG) levels | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 2件: 96 96, 97 |
526 | Diagnostic Test: Serum Metal ion levels determined to monitor changes in chromium and cobalt levels | 3件: Chromium Chromium, Cobalt, Methamidophos | - | - | - | 1件: 46 46 |
527 | Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 84 84 |
528 | Diagnostic Test: Six minute walking test | - | - | - | - | 1件: 113 113 |
529 | Diagnostic Test: Six-minute walk test (6MWT) | - | - | - | - | 3件: 3 3, 15, 256 |
530 | Diagnostic Test: Spanish-Complutense Verbal Learning Test (TAVEC) | - | - | - | - | 1件: 6 6 |
531 | Diagnostic Test: Spirometry | - | - | - | - | 1件: 84 84 |
532 | Diagnostic Test: Stroop test | - | - | - | - | 1件: 13 13 |
533 | Diagnostic Test: Supplementary Neuropsychological Assessment - Parkinson's Disease | - | - | - | - | 2件: 6 6, 127 |
534 | Diagnostic Test: Testing of autonomous nervous system function | - | - | - | - | 1件: 13 13 |
535 | Diagnostic Test: The Juvenile Disease Activity Score (JADAS) | - | - | - | - | 1件: 107 107 |
536 | Diagnostic Test: Thoracic CT scan | - | - | - | - | 1件: 229 229 |
537 | Diagnostic Test: Triptorelin acetate and Gonadorelin acetate | 3件: Acetate Acetate, Gonadorelin, Triptorelin | 5件: D00988
D00988
,
D03267
,
D04361
,
D06247
,
D08027
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 76 76 |
538 | Diagnostic Test: Upper member arterial Doppler echography with analysis of FMD | - | - | - | - | 1件: 58 58 |
539 | Diagnostic Test: Urodynamic Testing | - | - | - | - | 1件: 118 118 |
540 | Diagnostic Test: Vasculopathy assessment | - | - | - | - | 1件: 51 51 |
541 | Diagnostic Test: Vestibular/balance assessment | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 122 122 |
542 | Diagnostic Test: Vital signs | - | - | - | - | 3件: 3 3, 15, 256 |
543 | Diagnostic Test: Vitamin D Measurement | 1件: Vitamin D Vitamin D | - | - | - | 1件: 98 98 |
544 | Diagnostic Test: VOC probiotic | - | - | - | - | 1件: 294 294 |
545 | Diagnostic Test: Whole body Phe oxidation testing | - | - | - | - | 1件: 240 240 |
546 | Diagnostic Test: Xenon | 1件: Xenon Xenon | 2件: D01901
D01901
,
D06339
| - | - | 1件: 299 299 |
547 | Diammonium glycyrrhizinate enteric-coated capsule | - | - | - | - | 1件: 63 63 |
548 | Diastolic function SE | - | - | - | - | 3件: 58 58, 86, 215 |
549 | Diazepam | 1件: Diazepam Diazepam | 1件: D00293
D00293
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 46 46, 155, 298 |
550 | Diazepam, melatonin | 2件: Diazepam Diazepam, Melatonin | 2件: D00293
D00293
,
D08170
| 18件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, MTNR1A, MTNR1B 💬 | 8件: Circadian entrainment Circadian entrainment, GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 46 46 |
551 | Diazoxide | 1件: Diazoxide Diazoxide | 1件: D00294
D00294
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 2件: 13 13, 193 |
552 | DIAZOXIDE CHOLINE | 2件: Choline Choline, Diazoxide | 2件: D00294
D00294
,
D07690
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 |
553 | Diazoxide choline controlled-release tablet | 2件: Choline Choline, Diazoxide | 2件: D00294
D00294
,
D07690
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 |
554 | DIBASE | - | - | - | - | 1件: 13 13 |
555 | DIBASE*IM OS 2F 1ML 300000UI/M | - | - | - | - | 1件: 46 46 |
556 | Dichloroacetate | 1件: Dichloroacetic acid Dichloroacetic acid | - | - | - | 1件: 86 86 |
557 | Dichloroacetate Sodium | 1件: Dichloroacetic acid Dichloroacetic acid | - | - | - | 1件: 86 86 |
558 | Dichlorphenamide | 1件: Diclofenamide Diclofenamide | 1件: D00518
D00518
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 114 114 |
559 | Diclofenac | 1件: Diclofenac Diclofenac | 3件: D00903
D00903
,
D00904
,
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 5件: 13 13, 34, 46, 78, 271 |
560 | Diclofenac + Omeprazole | 2件: Diclofenac Diclofenac, Omeprazole | 7件: D00455
D00455
,
D00903
,
D00904
,
D01207
,
D05259
,
D05261
,
D07816
| 4件: ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | 26件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
561 | Diclofenac 50 milligrams | 1件: Diclofenac Diclofenac | 3件: D00903
D00903
,
D00904
,
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
562 | Diclofenac Sodium | 1件: Diclofenac Diclofenac | 3件: D00903
D00903
,
D00904
,
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 34 34, 46 |
563 | Diclofenac sodium topical gel | 1件: Diclofenac Diclofenac | 3件: D00903
D00903
,
D00904
,
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 |
564 | Diclofenac SR | 1件: Diclofenac Diclofenac | 3件: D00903
D00903
,
D00904
,
D07816
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
565 | Diclophenac | - | - | - | - | 1件: 271 271 |
566 | DICLOXACILLIN | 1件: Dicloxacillin Dicloxacillin | 2件: D02137
D02137
,
D02348
| - | - | 1件: 299 299 |
567 | Dicynone | - | - | - | - | 1件: 227 227 |
568 | Didanosine | 1件: Didanosine Didanosine | 1件: D00296
D00296
| - | - | 2件: 25 25, 265 |
569 | Diet | - | - | - | - | 3件: 97 97, 240, 299 |
570 | Diet 1 | - | - | - | - | 1件: 96 96 |
571 | Diet 2 | - | - | - | - | 1件: 96 96 |
572 | Diet A group | - | - | - | - | 1件: 85 85 |
573 | Diet B group | - | - | - | - | 1件: 85 85 |
574 | Diet C group | - | - | - | - | 1件: 85 85 |
575 | Dietanolamina de treprostinilo | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
576 | Dietary Fiber Supplementation | - | - | - | - | 1件: 46 46 |
577 | Dietary Supplement for PKU patients | - | - | - | - | 1件: 240 240 |
578 | Dietary supplement omega3 fatty acids aand vitamins | - | - | - | - | 1件: 46 46 |
579 | Dietary Supplement: vitamin A | 1件: Vitamin A Vitamin A | 2件: D00069
D00069
,
D06543
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 13 13 |
580 | Dietary therapy | - | - | - | - | 1件: 96 96 |
581 | Diethyl-[6-(4-hydroxycarbamoyl- phenyl carbamoyloxymethyl)-naphthalen-2-yl methyl]-ammonium chloride | 2件: Ammonium chloride Ammonium chloride, Chloride ion | 1件: D01139
D01139
| - | - | 1件: 107 107 |
582 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon | 2件: Ammonium chloride Ammonium chloride, Chloride ion | 1件: D01139
D01139
| - | - | 1件: 96 96 |
583 | Diethyldithiocarbamate | 1件: Ditiocarb Ditiocarb | - | - | - | 1件: 169 169 |
584 | Dietician designed diet | - | - | - | - | 1件: 96 96 |
585 | Difenidramina | - | - | - | - | 2件: 11 11, 63 |
586 | DIFENIDRAMINA CLORIDRATO | - | - | - | - | 2件: 11 11, 63 |
587 | Different diets | - | - | - | - | 1件: 6 6 |
588 | Different HAART regimens | - | - | - | - | 1件: 265 265 |
589 | Diflucan | 1件: Fluconazole Fluconazole | 2件: D00322
D00322
,
D01429
| - | - | 1件: 96 96 |
590 | Diflunisal | 1件: Diflunisal Diflunisal | 1件: D00130
D00130
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 |
591 | Diflunisal (dolobid) | 1件: Diflunisal Diflunisal | 1件: D00130
D00130
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 28 28 |
592 | Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone | - | - | - | - | 1件: 2 2 |
593 | Digital substraction angiography (DSA) | - | - | - | - | 1件: 40 40 |
594 | Digitoxin | 1件: Digitoxin Digitoxin | 1件: D00297
D00297
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
595 | DIGNA P144 CREAM | - | - | - | - | 1件: 51 51 |
596 | Digoxin | 1件: Digoxin Digoxin | 1件: D00298
D00298
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 8 8, 46, 210 |
597 | Digoxin 0.25 mg | 1件: Digoxin Digoxin | 1件: D00298
D00298
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
598 | Dihuang | 1件: Rehmannia glutinosa root Rehmannia glutinosa root | - | - | - | 3件: 46 46, 66, 76 |
599 | Dihydroartemisinin | 1件: Artenimol Artenimol | 1件: D07362
D07362
| - | - | 1件: 49 49 |
600 | Dihydroartemisinin tablet | 1件: Artenimol Artenimol | 1件: D07362
D07362
| - | - | 1件: 49 49 |
601 | Dihydroergotoxine | 1件: Dihydroergotoxine Dihydroergotoxine | 1件: D07839
D07839
| - | - | 1件: 6 6 |
602 | Dihydroergotoxine Mesylate | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate | 2件: D02268
D02268
,
D07839
| 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
603 | Dihydrogen | 1件: Hydrogen Hydrogen | - | - | - | 1件: 65 65 |
604 | DILATREND | - | - | - | - | 1件: 113 113 |
605 | Diltiazem | 1件: Diltiazem Diltiazem | 3件: D00616
D00616
,
D03830
,
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 58, 86 |
606 | Diltiazem Gel 2% | 1件: Diltiazem Diltiazem | 3件: D00616
D00616
,
D03830
,
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
607 | Diltiazem Hydrochloride | 1件: Diltiazem Diltiazem | 3件: D00616
D00616
,
D03830
,
D07845
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
608 | Dimebon | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
609 | Dimebon (latrepirdine) | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
610 | Dimebon + Dextromethorphan | 2件: Dextromethorphan Dextromethorphan, Latrepirdine | 4件: D00848
D00848
,
D03742
,
D03744
,
D09917
| 7件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
611 | Dimebon + Ketoconazole | 2件: Ketoconazole Ketoconazole, Latrepirdine | 2件: D00351
D00351
,
D09917
| 7件: ACHE ACHE, CYP17A1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 28件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
612 | Dimebon + Omeprazole | 2件: Latrepirdine Latrepirdine, Omeprazole | 5件: D00455
D00455
,
D01207
,
D05259
,
D05261
,
D09917
| 8件: ACHE ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 26件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
613 | Dimebon alone | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
614 | Dimebon Dihydrochloride | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
615 | Dimebon IR | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
616 | Dimebon IR Tablet | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
617 | Dimebon MR1 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
618 | Dimebon MR2 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
619 | Dimebon MR3 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
620 | Dimebon MR4 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
621 | Dimebon Transdermal | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
622 | DIMENSION | 1件: Dithiopyr Dithiopyr | - | - | - | 1件: 55 55 |
623 | DIMETHYL FUMARATE | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 4件: 13 13, 51, 86, 296 |
624 | Dimethyl Fumarate (DMF) | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 13 13, 51, 86 |
625 | Dimethyl fumarate 240 mg | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 |
626 | Dimethyl fumarate [DMF] | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 13 13 |
627 | Dimethyl sulfoxide | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
628 | Dimethyl sulfoxide (DMSO) | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
629 | Dimethylfumarat | 1件: Dimethyl fumarate Dimethyl fumarate | 1件: D03846
D03846
| 1件: KEAP1 KEAP1 💬 | 6件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 49 49 |
630 | DIMETIL-FUMARATO | - | - | - | - | 1件: 13 13 |
631 | Dimetilfumarato | - | - | - | - | 1件: 13 13 |
632 | Dimeythl Fumarate | - | - | - | - | 1件: 46 46 |
633 | DIMS0150 | - | - | - | - | 1件: 97 97 |
634 | DIOSMIN | 1件: Diosmin Diosmin | 1件: D07858
D07858
| - | - | 1件: 265 265 |
635 | Diosminex, 500 mg, tabletki powlekane | - | - | - | - | 1件: 265 265 |
636 | Diovan | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
637 | Diovan 160 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
638 | Diovan 40 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
639 | Diovan 80 mg | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
640 | Diphenhydramine | 1件: Diphenhydramine Diphenhydramine | 6件: D00300
D00300
,
D00669
,
D02419
,
D03285
,
D03360
,
D03854
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 10件: 11 11, 13, 49, 51, 70, 86, 96, 222, 256, 300 |
641 | Diphenhydramine hydrochloride | 1件: Diphenhydramine Diphenhydramine | 6件: D00300
D00300
,
D00669
,
D02419
,
D03285
,
D03360
,
D03854
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 11 11, 49 |
642 | Diphenhydramine IV | 1件: Diphenhydramine Diphenhydramine | 6件: D00300
D00300
,
D00669
,
D02419
,
D03285
,
D03360
,
D03854
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
643 | Diphenydramine | - | - | - | - | 1件: 13 13 |
644 | Diphtheria toxoid | 1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | - | - | - | 2件: 13 13, 46 |
645 | Dipivefrin | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
646 | Dipivefrine | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
647 | Dipotassium Salt | - | - | - | - | 1件: 46 46 |
648 | Dipraglurant | 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 |
649 | Diprofos Depot | - | - | - | - | 1件: 46 46 |
650 | Dipyridamole | 1件: Dipyridamole Dipyridamole | 1件: D00302
D00302
| 2件: PDE4A PDE4A, PDE5A 💬 | 6件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 46 46, 49, 51, 66, 96, 224 |
651 | Dipyridamole and Amoxapine | 2件: Amoxapine Amoxapine, Dipyridamole | 2件: D00228
D00228
,
D00302
| 4件: PDE4A PDE4A, PDE5A, SLC6A2, SLC6A4 💬 | 8件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
652 | Dipyridamole Tab 25 MG | 1件: Dipyridamole Dipyridamole | 1件: D00302
D00302
| 2件: PDE4A PDE4A, PDE5A 💬 | 6件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 224 224 |
653 | Diquafosol | 1件: Diquafosol Diquafosol | - | - | - | 1件: 53 53 |
654 | Diroximel fumarate | 1件: Diroximel fumarate Diroximel fumarate | 1件: D11154
D11154
| - | - | 1件: 13 13 |
655 | Diroximel Fumarate (DRF) | 1件: Diroximel fumarate Diroximel fumarate | 1件: D11154
D11154
| - | - | 1件: 13 13 |
656 | Dirucotide | 1件: Dirucotide Dirucotide | 1件: D09396
D09396
| - | - | 1件: 13 13 |
657 | Dirucotide acetate | 2件: Acetate Acetate, Dirucotide | 1件: D09396
D09396
| - | - | 1件: 13 13 |
658 | Discontinuation of disease modifying therapy | - | - | - | - | 1件: 13 13 |
659 | Disease modified antirheumatic drugs or biological agents | - | - | - | - | 1件: 46 46 |
660 | Disease Modifying therapy | - | - | - | - | 1件: 13 13 |
661 | Disease modifying treatment (DMT) | - | - | - | - | 1件: 13 13 |
662 | Disease-modifying anti-rheumatic drugs | - | - | - | - | 1件: 46 46 |
663 | Disease-modifying antirheumatic drug | - | - | - | - | 1件: 46 46 |
664 | Disease-modifying antirheumatic drugs (DMARDs) | - | - | - | - | 1件: 46 46 |
665 | Disodium citrate | - | - | - | - | 1件: 245 245 |
666 | Disodium cromoglycate (DSCG) | 1件: Cromoglicic acid Cromoglicic acid | 2件: D00526
D00526
,
D07753
| - | - | 1件: 85 85 |
667 | Disodium Cromoglycate [cromolyn sodium] | 1件: Cromoglicic acid Cromoglicic acid | 2件: D00526
D00526
,
D07753
| - | - | 1件: 85 85 |
668 | Disodium Pamidronate 15mg (15mg strength) | 1件: Pamidronic acid Pamidronic acid | 2件: D00941
D00941
,
D07281
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
669 | Disodium Pyrophosphate | - | - | - | - | 1件: 166 166 |
670 | Disodiumpyrophosphate | - | - | - | - | 1件: 166 166 |
671 | Ditropan elixir | 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
672 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) | 1件: Amiodarone Amiodarone | 2件: D00636
D00636
,
D02910
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 |
673 | Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus EGCG | 2件: Amiodarone Amiodarone, Epigallocatechin gallate | 2件: D00636
D00636
,
D02910
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 32件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 28 28 |
674 | DIURF-006 | - | - | - | - | 1件: 81 81 |
675 | Divalproex | - | - | - | - | 1件: 8 8 |
676 | Divalproex sodium | - | - | - | - | 1件: 51 51 |
677 | Dl-3-n-butylphthalide (NBP) | 1件: Butylphthalide Butylphthalide | - | - | - | 1件: 22 22 |
678 | DLX105 | - | - | - | - | 1件: 96 96 |
679 | DM | - | - | - | - | 2件: 6 6, 8 |
680 | DM-1992 | - | - | - | - | 1件: 6 6 |
681 | DMARD | - | - | - | - | 1件: 46 46 |
682 | DMARD cessation | - | - | - | - | 1件: 46 46 |
683 | DMARD maintenance | - | - | - | - | 1件: 46 46 |
684 | DMARD Therapy | - | - | - | - | 1件: 46 46 |
685 | DMARDS | - | - | - | - | 2件: 46 46, 271 |
686 | DMARDs (disease-modifying antirheumatic drugs) | - | - | - | - | 1件: 46 46 |
687 | DMARDs (methotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
688 | DMARDs or Biologics | - | - | - | - | 1件: 46 46 |
689 | DMPS | 1件: 2,3-Dimercapto-1-propanesulfonic acid 2,3-Dimercapto-1-propanesulfonic acid | - | - | - | 1件: 171 171 |
690 | DMSA | 1件: Succimer Succimer | 1件: D00572
D00572
| - | - | 1件: 171 171 |
691 | DMSO | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
692 | DMSO cocktail | 1件: Dimethyl sulfoxide Dimethyl sulfoxide | 1件: D01043
D01043
| - | - | 1件: 226 226 |
693 | DMT | - | - | - | - | 1件: 13 13 |
694 | DMT continuation | - | - | - | - | 1件: 13 13 |
695 | DMX-200 | - | - | - | - | 1件: 222 222 |
696 | DnaJ peptide | - | - | - | - | 1件: 46 46 |
697 | DNL151 | - | - | - | - | 1件: 6 6 |
698 | DNL201 | - | - | - | - | 1件: 6 6 |
699 | DNL310 | - | - | - | - | 1件: 19 19 |
700 | DNL310 Drug Substance | - | - | - | - | 1件: 19 19 |
701 | DNL343 | - | - | - | - | 1件: 2 2 |
702 | DNL593 | - | - | - | - | 1件: 127 127 |
703 | DNL747 | - | - | - | - | 1件: 2 2 |
704 | DNS-7801 (high dose) | - | - | - | - | 1件: 6 6 |
705 | DNS-7801 (low-dose) | - | - | - | - | 1件: 6 6 |
706 | Dobutamin | 1件: Dobutamine Dobutamine | 4件: D00632
D00632
,
D03879
,
D03880
,
D03881
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
707 | Dobutamine | 1件: Dobutamine Dobutamine | 4件: D00632
D00632
,
D03879
,
D03880
,
D03881
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 57 57, 58, 215 |
708 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
709 | Docosahexaenoic Acid (DHA) | 1件: Doconexent Doconexent | - | - | - | 3件: 6 6, 94, 299 |
710 | Docosahexaenoic Acid (DHA) Dietary Supplement | 1件: Doconexent Doconexent | - | - | - | 1件: 301 301 |
711 | Docosahexaenoic acid administration: 50 mg/kg/day during 12 months | 1件: Doconexent Doconexent | - | - | - | 1件: 299 299 |
712 | Docosahexanoic Acid Supplement | - | - | - | - | 1件: 299 299 |
713 | Dolobid | - | - | - | - | 1件: 28 28 |
714 | Dolquine | - | - | - | - | 1件: 46 46 |
715 | Dolutegravir | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 2件: 2 2, 265 |
716 | Dolutegravir / Lamivudine Oral Tablet | 2件: Dolutegravir Dolutegravir, Lamivudine | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
717 | Dolutegravir 50 MG | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 1件: 265 265 |
718 | Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO] | 2件: Dolutegravir Dolutegravir, Lamivudine | 2件: D00353
D00353
,
D10066
| - | - | 1件: 265 265 |
719 | Domperidone | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
720 | Domperidone (drug) | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
721 | Dompéridone | - | - | - | - | 1件: 6 6 |
722 | Donepezil | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
723 | Donepezil HCI (drug) | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 13 13 |
724 | Donepezil hydrochloride | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 6 6, 124, 156 |
725 | Donepezil Sandoz | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
726 | Donor Lymphocyte Infusion | - | - | - | - | 1件: 60 60 |
727 | Donor Lymphocyte Infusion (DLI) | - | - | - | - | 1件: 60 60 |
728 | Donor lymphocytes | - | - | - | - | 1件: 28 28 |
729 | Donor mesenchymal stem cell infusions | - | - | - | - | 1件: 36 36 |
730 | Donor mobilized PBSC infusion | - | - | - | - | 2件: 60 60, 285 |
731 | Donor peripheral blood stem cells. | - | - | - | - | 1件: 65 65 |
732 | DopaFuse Delivery System | - | - | - | - | 1件: 6 6 |
733 | Dopamina | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 299 299 |
734 | Dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 7, 74 |
735 | Dopamine Agent | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
736 | Dopamine agonist treatment | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 |
737 | Dopamine Agonists | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 74 74 |
738 | Dopamine Agonists (pramipexole, ropirinole) | 2件: Dopamine Dopamine, Pramipexole | 4件: D00559
D00559
,
D00633
,
D05575
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
739 | Dopaminergic Agonist + Apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
740 | Dopaminergic Agonists | - | - | - | - | 1件: 6 6 |
741 | Doppler ultrasound | - | - | - | - | 1件: 49 49 |
742 | Doppler ultrasound. | - | - | - | - | 1件: 46 46 |
743 | DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 17 |
744 | Doptelet | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
745 | Doptelet 20 mg film-coated tablets | 1件: Avatrombopag Avatrombopag | 1件: D10306
D10306
| 1件: MPL MPL 💬 | 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 63 63 |
746 | Doravirine | 1件: Doravirine Doravirine | 1件: D10624
D10624
| - | - | 1件: 265 265 |
747 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] | 3件: Doravirine Doravirine, Tenofovir, Tenofovir disoproxil | 3件: D01982
D01982
,
D06074
,
D10624
| - | - | 1件: 265 265 |
748 | DORIBAX | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
749 | Doripenem | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
750 | DORIPENEM HYDRATE | 1件: Doripenem Doripenem | 1件: D03895
D03895
| - | - | 1件: 299 299 |
751 | Dornase alfa | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 2件: 53 53, 299 |
752 | Dornase alfa (Pulmozyme) | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
753 | Dornase alfa [Pulmozyme®] | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
754 | Dornase alpha | 1件: Dornase alfa Dornase alfa | 1件: D03896
D03896
| - | - | 1件: 299 299 |
755 | Dorzolamide | 1件: Dorzolamide Dorzolamide | 2件: D00653
D00653
,
D07871
| 13件: CA1 CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 | 7件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 90 90 |
756 | Dose level 1 | - | - | - | - | 1件: 46 46 |
757 | Dose level 2 | - | - | - | - | 1件: 46 46 |
758 | Dose level 3 | - | - | - | - | 1件: 46 46 |
759 | Dose level 4 | - | - | - | - | 1件: 46 46 |
760 | Dose of 60 mg/kg alpha1-proteinase inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
761 | Dose of 60 mg/kg Fraction IV-1 Alpha1-Proteinase Inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | - | - | - | 1件: 231 231 |
762 | Dose-Establishing Study 1 Niacin 250mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
763 | Dose-Establishing Study 1 Niacin 500mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
764 | Dose-Establishing Study 2 Niacin 500mg | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 1件: 78 78 |
765 | Dosing Extension | - | - | - | - | 1件: 113 113 |
766 | Dosing Interruption of Natalizumab | 1件: Natalizumab Natalizumab | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
767 | DOSTINEX | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 75 75 |
768 | DOTA-TATE | 1件: Dotatate Dotatate | - | - | - | 1件: 238 238 |
769 | DOTANOC | - | - | - | - | 1件: 84 84 |
770 | Dotarem | 1件: Gadoteric acid Gadoteric acid | 1件: D08007
D08007
| - | - | 1件: 13 13 |
771 | Dotarem 0,5mmol/ml, | 1件: Gadoteric acid Gadoteric acid | 1件: D08007
D08007
| - | - | 1件: 13 13 |
772 | Dotatate | 1件: Dotatate Dotatate | - | - | - | 4件: 41 41, 75, 84, 238 |
773 | Double-blind Abatacept | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
774 | Double-blind adalimumab | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 |
775 | Double-Blind Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 51 51 |
776 | Doxazosin | 1件: Doxazosin Doxazosin | 2件: D00608
D00608
,
D07874
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 57 57, 67 |
777 | Doxepin | 1件: Doxepin Doxepin | 2件: D00814
D00814
,
D07875
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
778 | Doxepin and Zopiclone | 2件: Doxepin Doxepin, Zopiclone | 3件: D00814
D00814
,
D01372
,
D07875
| 19件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 | 10件: Calcium signaling pathway Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬 | 1件: 6 6 |
779 | Doxil | - | - | - | - | 1件: 63 63 |
780 | Doxorubicin | 1件: Doxorubicin Doxorubicin | 1件: D03899
D03899
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 5件: 26 26, 28, 34, 65, 331 |
781 | Doxorubicin Hydrochloride | 1件: Doxorubicin Doxorubicin | 1件: D03899
D03899
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 3件: 26 26, 34, 331 |
782 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase | 4件: Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate | 6件: D00142
D00142
,
D00287
,
D02115
,
D02997
,
D03899
,
D07760
| 4件: DHFR DHFR, DHFR2, TOP2A, TOP2B 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | 1件: 65 65 |
783 | Doxycyclin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 2件: 97 97, 299 |
784 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 16件: 13 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 |
785 | Doxycycline 100 mg Capsules | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 89 89 |
786 | Doxycycline 100-200mg capsules daily for 6 months | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 167 167 |
787 | DOXYCYCLINE HYCLATE | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 3件: 23 23, 96, 227 |
788 | Doxycycline Hyclate Ph.Eur | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 167 167 |
789 | Doxycycline Tablets | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 46 46 |
790 | DoxyHEXAL® tabs 100 mg Tabletten | - | - | - | - | 1件: 28 28 |
791 | DP Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
792 | DPA | - | - | - | - | 5件: 2 2, 6, 13, 85, 127 |
793 | DPA-714 PET/MRI | - | - | - | - | 1件: 13 13 |
794 | DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 |
795 | DPPG | - | - | - | - | 1件: 79 79 |
796 | Dr. Reddy’s Rituximab (DRL_RI) 100mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
797 | Dr. Reddy’s Rituximab (DRL_RI) 500mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
798 | Dried blood spot (DBS) sampling | - | - | - | - | 1件: 19 19 |
799 | Drisapersen | 1件: Drisapersen Drisapersen | 1件: D10114
D10114
| 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
800 | DRISAPERSEN SODIUM | 1件: Drisapersen Drisapersen | 1件: D10114
D10114
| 1件: DMD DMD 💬 | 4件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 |
801 | DRL_RI | - | - | - | - | 1件: 46 46 |
802 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 5件: 2 2, 13, 46, 271, 298 |
803 | Dronabinol 25 mg/ml, oral drops | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 |
804 | Dronabinol capsule 2,5 mg | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 13 13 |
805 | Dronabinol capsule 2.5. mg | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 46 46, 271 |
806 | Drops | - | - | - | - | 2件: 50 50, 107 |
807 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
808 | Droxidopa 100 MG [Northera] | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
809 | Drug - SHR1459 | - | - | - | - | 1件: 13 13 |
810 | Drug coated balloon (DCB) | - | - | - | - | 1件: 40 40 |
811 | Drug free, IS monotherapy and GC combined with IS | - | - | - | - | 1件: 300 300 |
812 | Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom | - | - | - | - | 2件: 46 46, 49 |
813 | Drug protocol | - | - | - | - | 1件: 46 46 |
814 | Drug treatment | - | - | - | - | 4件: 46 46, 51, 74, 271 |
815 | Drug-Carbamazepine (Tegretol XR) | 1件: Carbamazepine Carbamazepine | 1件: D00252
D00252
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 231 231 |
816 | Drug: Abatacept | 1件: Abatacept Abatacept | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 12件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 46 46 |
817 | Drug: F 18 T807 | - | - | - | - | 1件: 2 2 |
818 | Drug: Salirumab | - | - | - | - | 1件: 46 46 |
819 | Drug: Tocilizmab | - | - | - | - | 1件: 46 46 |
820 | Drug: Topical Rapamycin | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 157 157 |
821 | DRX005B | - | - | - | - | 1件: 19 19 |
822 | Dry powder tobramycin | 1件: Tobramycin Tobramycin | 2件: D00063
D00063
,
D02542
| - | - | 1件: 299 299 |
823 | DS-5141b | - | - | - | - | 1件: 113 113 |
824 | DS-6016a | - | - | - | - | 1件: 272 272 |
825 | DS-7011a | - | - | - | - | 1件: 49 49 |
826 | DSG3-CAART | - | - | - | - | 1件: 35 35 |
827 | DT-216 | - | - | - | - | 1件: 18 18 |
828 | DTPA | 1件: Pentetic acid Pentetic acid | 1件: D05422
D05422
| - | - | 2件: 28 28, 299 |
829 | DTR Melatonin (NIH CC PDS) | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
830 | DTX301 | - | - | - | - | 1件: 251 251 |
831 | Dual Energy X-ray Absorptiometry (DEXA) | - | - | - | - | 1件: 299 299 |
832 | Dual release hydrocortisone (plenadren) | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
833 | Dukoral | 1件: Recombinant Cholera Toxin B Subunit Recombinant Cholera Toxin B Subunit | - | - | - | 1件: 97 97 |
834 | Dulaglutide | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
835 | Dulaglutide 0.75Mg/0.5Ml Inj Pen | 1件: Dulaglutide Dulaglutide | 1件: D09889
D09889
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 299 299 |
836 | Duloxetine | 1件: Duloxetine Duloxetine | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
837 | Duloxetine hydrochloride | 1件: Duloxetine Duloxetine | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
838 | Duloxetine Hydrochloride (HCI) | 1件: Duloxetine Duloxetine | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 |
839 | Dummy Qing Re Huo Xue (QRHX) | - | - | - | - | 1件: 46 46 |
840 | Duo-Therapy with Sildenafil + Bosentan | 2件: Bosentan Bosentan, Sildenafil | 4件: D01227
D01227
,
D02229
,
D07538
,
D08514
| 3件: EDNRA EDNRA, EDNRB, PDE5A 💬 | 11件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
841 | DUOC-01 | - | - | - | - | 3件: 13 13, 19, 20 |
842 | DUODOPA | - | - | - | - | 1件: 6 6 |
843 | Duodopa gel intestinale | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
844 | Duodopa intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
845 | Duodopa intestinalgel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
846 | Duodopa LD/CD 20/5 mg/mL | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
847 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
848 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
849 | DUODOPA®Intestinal Gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
850 | Dupilumab | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 4件: 51 51, 98, 160, 162 |
851 | Dupilumab (blinded) | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 |
852 | Dupilumab (open-label) | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 98 98 |
853 | Dupilumab 300Mg Solution for Injection | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 51 51 |
854 | Dupilumab Injection | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 |
855 | Dupilumab Prefilled Syringe | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 160 160 |
856 | Dupixent | 1件: Dupilumab Dupilumab | 1件: D10354
D10354
| 1件: IL4R IL4R 💬 | 8件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 3件: 98 98, 160, 162 |
857 | DUR-928 | - | - | - | - | 1件: 94 94 |
858 | DURAMYCIN | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
859 | Duramycin, 2622U90 | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
860 | Durvalumab | 1件: Durvalumab Durvalumab | 1件: D10808
D10808
| 1件: CD274 CD274 💬 | 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 |
861 | Dutasterida | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 2 2 |
862 | Dutasteride | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 2件: 1 1, 2 |
863 | Duvoglustat | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
864 | Duvoglustat HCl | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
865 | Duvoglustat hydrochloride | 1件: Duvoglustat Duvoglustat | 1件: D09605
D09605
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
866 | DW1809 | - | - | - | - | 1件: 46 46 |
867 | DW1809-1 | - | - | - | - | 1件: 46 46 |
868 | DW1809-T2 | - | - | - | - | 1件: 46 46 |
869 | DWN12088 | - | - | - | - | 1件: 85 85 |
870 | DWP422 25mg | - | - | - | - | 1件: 46 46 |
871 | DX-890 | - | - | - | - | 1件: 299 299 |
872 | DYDROGESTERONE | 1件: Dydrogesterone Dydrogesterone | 1件: D01217
D01217
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
873 | DYN101 | - | - | - | - | 1件: 111 111 |
874 | Dynacirc CR (Isradipine) | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
875 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging | - | - | - | - | 1件: 13 13 |
876 | Dynamic Vessel Analyzer (DVA) | - | - | - | - | 1件: 13 13 |
877 | Dyphenhydramine hydrochloride | - | - | - | - | 1件: 63 63 |
878 | Dysmorphology evaluation | - | - | - | - | 1件: 78 78 |
879 | Dysport | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 13 13, 36 |
880 | DYSPORT*SC IM 2FL 500U | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
881 | DYSPORT® | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 13 13 |
882 | Dysport® (Botulinumtoxin A (Btx A)) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 36 36 |
883 | DZP | - | - | - | - | 1件: 49 49 |
884 | Désogestrel | 1件: Desogestrel Desogestrel | 1件: D02367
D02367
| 2件: ESR1 ESR1, PGR 💬 | 11件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 230 230 |